Associated Papers
Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.
Lawrence-Paul MR et al.
Genome Medicine, 2024
38321573 (PubMed )
Supplement: 13073_2024_1293_MOESM2_ESM.xlsx › MetSpec_WES_mutations
Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
Wu X et al.
Bmc Cancer, 2022
Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.
Richter-Pechańska P et al.
Blood Cancer Journal, 2017
28157215 (PubMed )
Supplement: bcj20173x11.xlsx › SNVsInDelsCalled_in214Pts
[Pedigree investigation of clinicopathologic features and alpha-galactosidase A gene mutation in a family with Fabry disease].
Liu XX et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition, 2012
[Investigation of family pedigree rare blood group of JK(a-b-) phenotype].
Gong TX et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2012
[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].
Zhu JF et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2011
[Mutation of tet2 gene and malignant blood disease].
Qian XF et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2010
[Report of gene mutation hot spots analysis in one congenital cataract pedigree].
Zhang X et al.
Yan Ke Xue Bao = Eye Science, 2004
Select a paper to view details